A primer on cost-effectiveness analyses for vascular surgeons

Journal of Vascular Surgery

Volumn 55, Issue 6, 2012, Pages 1794-1800

  Barshes, Neal R ^a   Chambers, James D ^b   Cantor, Scott B ^c   Cohen, Joshua ^b   Belkin, Michael ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SURGEON; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGERY;

EID: 84862099412     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.02.026     Document Type: Review

References (52)

1. G.P. Clagett Does vascular surgery cost too much? J Vasc Surg 50 2009 1211 1218
2. INAHTA I Health technology assessment (HTA) glossary [internet] http://inahta.episerverhotell.net/HTA/Glossary/ Accessed July 6, 2011
3. A. Azoulay, N.M. Doris, K.B. Filion, J. Caron, L. Pilote, M.J. Eisenberg The use of the transition cost accounting system in health services research Cost Eff Resour Alloc 5 2007 11
4. T.K. Ross Analyzing health care operations using ABC J Health Care Finance 30 2004 1 20
5. S.A. Finkler The distinction between cost and charges Ann Intern Med 96 1982 102 109
6. D.K. Owens, A. Qaseem, R. Chou, P. Shekelle Clinical Guidelines Committee of the American College of Physicians High-value, cost-conscious health care: Concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions Ann Intern Med 154 2011 174 180
7. M. Hunink, P. Glasziou Decision making in health and medicine: integrating evidence and values 2009 Cambridge University Press New York
8. A. Thoma, L.L. McKnight Quality-adjusted life-year as a surgical outcome measure: a primer for plastic surgeons Plast Reconstr Surg 125 2010 1279 1287
9. National Health Service, National Institute for Health and Clinical Excellence The guidelines manual, 2009 http://www.nice.org.uk/guidelinesmanual Accessed: July 6, 2011
10. P.A. Ubel, R.A. Hirth, M.E. Chernew, A.M. Fendrick What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 163 2003 1637 1641
11. M.C. Weinstein How much are Americans willing to pay for a quality-adjusted life year? Med Care 46 2008 343 345
12. S.M. Taylor, B.L. Johnson, N.L. Samies, R.D. Rawlinson, L.E. Williamson, S.A. Davis Contemporary management of diabetic neuropathic foot ulceration: A study of 917 consecutively treated limbs J Am Coll Surg 212 2011 532 545 discussion: 546-8
13. A.W. Bradbury Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial in perspective J Vasc Surg 51 5 Suppl 2010 1S 4S
14. S.M. Taylor Current status of heroic limb salvage for critical limb ischemia Am Surg 74 2008 275 284
15. A.I. Auer, J.J. Hurley, H.B. Binnington, J.D. Nunnelee, F.B. Hershey Distal tibial vein grafts for limb salvage Arch Surg 118 1983 597 602
16. W.C. Mackey, J.L. McCullough, T.P. Conlon, A.D. Shepard, R.A. Deterling, A.D. Callow The costs of surgery for limb-threatening ischemia Surgery 99 1986 26 35
17. C.A. Raviola, L.S. Nichter, J.D. Baker, R.W. Busuttil, H.I. Machleder, W.S. Moore Cost of treating advanced leg ischemia Bypass graft vs primary amputation Arch Surg 123 1988 495 496
18. S.K. Gupta, F.J. Veith, E. Ascer, S.A. Flores, M.L. Gliedman Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis Eur J Vasc Surg 2 1988 151 154
19. N.J. Cheshire, J.H. Wolfe, M.A. Noone, L. Davies, M. Drummond The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein J Vasc Surg 15 1992 167 174 discussion: 174-5
20. B.A. Perler Cost-efficacy issues in the treatment of peripheral vascular disease: Primary amputation or revascularization for limb-threatening ischemia J Vasc Interv Radiol 6 Suppl 1995 111S 115S
21. B.F. Johnson, L. Evans, R. Drury, D. Datta, W. Morris-Jones, J.D. Beard Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits Eur J Vasc Endovasc Surg 9 1995 181 188
22. S. Singh, L. Evans, D. Datta, P. Gaines, J.D. Beard The costs of managing lower limb-threatening ischaemia Eur J Vasc Endovasc Surg 12 1996 359 362
23. T.E. Brothers, G.A. Rios, J.G. Robison, B.M. Elliot Justification of intervention for limb-threatening ischemia: a surgical decision analysis Cardiovasc Surg 7 1999 62 69
24. M.G. Hunink, K.A. Cullen, M.C. Donaldson Hospital costs of revascularization procedures for femoropopliteal arterial disease J Vasc Surg 19 1994 632 641
25. M.G. Hunink, J.B. Wong, M.C. Donaldson, M.F. Meyerovitz, J. de Vries, D.P. Harrington Revascularization for femoropopliteal disease A decision and cost-effectiveness analysis JAMA 274 1995 165 171
26. S. Spronk, J.L. Bosch, P.T. den Hoed, H.F. Veen, P.M. Pattynama, M.G. Hunink Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial J Vasc Surg 48 2008 1472 1480
27. K.M. Kuntz, K.C. Kent Is carotid endarterectomy cost-effective? An analysis of symptomatic and asymptomatic patients Circulation 94 9 Suppl 1996 II194 II198
28. S.T. Patel, P.B. Haser, P. Korn, H.L. Bush Jr, J.S. Deitch, K.C. Kent Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis? J Vasc Surg 30 1999 1024 1033
29. E.S. Nussbaum, R.C. Heros, D.L. Erickson Cost-effectiveness of carotid endarterectomy Neurosurgery 38 1996 237 244
30. J.L. Cronenwett, J.D. Birkmeyer, G.B. Nackman, M.F. Fillinger, F.R. Bech, R.M. Zwolak Cost-effectiveness of carotid endarterectomy in asymptomatic patients J Vasc Surg 25 1997 298 309 discussion: 310-1
31. M. Henriksson, F. Lundgren, P. Carlsson Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis Br J Surg 95 2008 714 720
32. S. Kilaru, P. Korn, K. Kasirajan, T.Y. Lee, F.P. Beavers, R.T. Lyon Is carotid angioplasty and stenting more cost effective than carotid endarterectomy? J Vasc Surg 37 2003 331 339
33. M.P. Janssen, G.J. de Borst, W.P. Mali, L.J. Kappelle, F.L. Moll, R.G. Ackerstaff Carotid stenting versus carotid endarterectomy: Evidence basis and cost implications Eur J Vasc Endovasc Surg 36 2008 258 264 discussion: 265-6
34. K.C. Young, R.G. Holloway, W.S. Burgin, C.G. Benesch A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy J Stroke Cerebrovasc Dis 19 2010 404 409
35. E.M. Mahoney, D. Greenberg, T.A. Lavelle, A. Natarajan, R. Berezin, K.J. Ishak Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: Results from the SAPPHIRE trial Catheter Cardiovasc Interv 77 2011 463 472
36. N.A. Obuchowski, M.T. Modic, M. Magdinec, T.J. Masaryk Assessment of the efficacy of noninvasive screening for patients with asymptomatic neck bruits Stroke 28 1997 1330 1339
37. D. Yin, J.P. Carpenter Cost-effectiveness of screening for asymptomatic carotid stenosis J Vasc Surg 27 1998 245 255
38. S.T. Patel, K.M. Kuntz, K.C. Kent Is routine duplex ultrasound surveillance after carotid endarterectomy cost-effective? Surgery 124 1998 343 351 discussion: 351-2
39. P.D. Hayes, U. Sadat, S.R. Walsh, A. Noorani, T.Y. Tang, D.J. Bowden Cost-effectiveness analysis of endovascular versus open surgical repair of acute abdominal aortic aneurysms based on worldwide experience J Endovasc Ther 17 2010 174 182
40. G. Blackhouse, R. Hopkins, J.M. Bowen, G. De Rose, T. Novick, J.E. Tarride A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada Value Health 12 2009 245 252
41. K.C. Young, N.A. Awad, M. Johansson, D. Gillespie, M.J. Singh, K.A. Illig Cost-effectiveness of abdominal aortic aneurysm repair based on aneurysm size J Vasc Surg 51 2010 27 32 discussion: 32
42. H. Xue, E. Lacson Jr, W. Wang, G.C. Curhan, S.M. Brunelli Choice of vascular access among incident hemodialysis patients: A decision and cost-utility analysis Clin J Am Soc Nephrol 5 2010 2289 2296
43. S.E. Rosas, H.I. Feldman Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis Ann Surg 255 2012 181 186
44. C. Black, P. Sharma, G. Scotland, K. McCullough, D. McGurn, L. Robertson Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis Health Technol Assess 14 2010 1 184
45. J.D. Chambers, P.J. Neumann Listening to Provenge-what a costly cancer treatment says about future Medicare policy N Engl J Med 364 2011 1687 1689
46. M. Porter, E. Olmsted Teisberg Redefining Health Care: creating value-based competition on results 2006 Harvard Business Press Boston
47. Congressional Budget Office Research on the comparative effectiveness of medical treatments: issues and options for an expanded Federal role [internet] 2007 Congressional Budget Office Washington DC http://www.cbo.gov/publication/ 41655 Accessed July 6, 2011
48. P.J. Neumann, A.B. Rosen, M.C. Weinstein Medicare and cost-effectiveness analysis N Engl J Med 353 2005 1516 1522
49. P.J. Neumann, S.R. Tunis Medicare and medical technology-the growing demand for relevant outcomes N Engl J Med 362 2010 377 379
50. D. Eddy Reflections on science, judgment, and value in evidence-based decision making: A conversation with David Eddy by Sean R. Tunis Health Aff (Millwood) 26 2007 w500 w515
51. S.R. Tunis, S.D. Pearson US moves to improve health decisions BMJ 341 2010 c3615
52. K. Adams Rethinking comparative effectiveness research: an interview with Dr. Donald Berwick Biotechnol Healthc 6 2009 35 38